Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schuler

Showing results (91-100 of 297) with videos related to

Pageof 30
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 9, 2023
Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancerÖzlem Okumus, Khaled Mardanzai, Till Plönes, et al.
Inflammatory Bowel Diseases|September 29, 2009
Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancerMaximilian J Waldner, Stefan Wirtz, Christoph Becker, et al.
Frontiers in Oncology|May 16, 2022
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: An Updated Database of 1023 Cases Brief ReportJames Chih-Hsin Yang, Martin Schuler, Sanjay Popat, et al.
The Annals of Thoracic Surgery|February 6, 2019
Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine CarcinomaDanjouma Housmanou Cheufou, Daniel Valdivia, Stephan Puhlvers, et al.
Journal of Thoracic Disease|April 30, 2015
Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyChristoph Pöttgen, Jehad Abu Jawad, Eleni Gkika, et al.
Plos One|January 28, 2014
Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patientsFrank Breitenbuecher, Sandra Hoffarth, Karl Worm, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 8, 2010
The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trialMartin Sebastian, Martin Reck, Cornelius F Waller, et al.
Neoplasia (New York, N.Y.)|August 7, 2010
MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapyAndreas-Claudius Hoffmann, Peter Wild, Christina Leicht, et al.
Frontiers in Oncology|May 31, 2021
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including CetuximabMichael Pogorzelski, Thomas Hilser, Saskia C Ting, et al.
Annals of Surgical Oncology|July 19, 2012
Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinomaBenjamin Juntermanns, Georgios Charalambos Sotiropoulos, Sonia Radunz, et al.
Pageof 30

Showing results (91-100 of 297) with videos related to

Sort By:
Pageof 30
Lung Cancer (Amsterdam, Netherlands)|January 9, 2023
Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancerÖzlem Okumus, Khaled Mardanzai, Till Plönes, et al.
Inflammatory Bowel Diseases|September 29, 2009
Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancerMaximilian J Waldner, Stefan Wirtz, Christoph Becker, et al.
Frontiers in Oncology|May 16, 2022
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: An Updated Database of 1023 Cases Brief ReportJames Chih-Hsin Yang, Martin Schuler, Sanjay Popat, et al.
The Annals of Thoracic Surgery|February 6, 2019
Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine CarcinomaDanjouma Housmanou Cheufou, Daniel Valdivia, Stephan Puhlvers, et al.
Journal of Thoracic Disease|April 30, 2015
Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyChristoph Pöttgen, Jehad Abu Jawad, Eleni Gkika, et al.
Plos One|January 28, 2014
Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patientsFrank Breitenbuecher, Sandra Hoffarth, Karl Worm, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 8, 2010
The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trialMartin Sebastian, Martin Reck, Cornelius F Waller, et al.
Neoplasia (New York, N.Y.)|August 7, 2010
MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapyAndreas-Claudius Hoffmann, Peter Wild, Christina Leicht, et al.
Frontiers in Oncology|May 31, 2021
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including CetuximabMichael Pogorzelski, Thomas Hilser, Saskia C Ting, et al.
Annals of Surgical Oncology|July 19, 2012
Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinomaBenjamin Juntermanns, Georgios Charalambos Sotiropoulos, Sonia Radunz, et al.
Pageof 30